ArticleBlood advances2022
Lissitchkov T, Willemze A, Katragadda S, et al. Efanesoctocog alfa for hemophilia A: results from a phase 1 repeat-dose study. Blood Adv. 2022;6(4):1089-1094.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.